Successful diagnostic product development requires the best laboratory conditions and equipment. www.youtube.com/watch?v=j_me...

Transformative Medical Diagnostics www.youtube.com/watch?v=UHKz...

A @liverpooluni.bsky.social led research team has been awarded more than £475,000 from Blood Cancer UK to continue and expand UNCOVER, one of the largest blood cancer data research programmes in the world. 👉 news.liverpool.ac.uk/2026/06/17/n...

At its core, a companion diagnostic enables a simple yet powerful shift: treating the right patient, with the right drug, at the right time. CDx allows therapies to be targeted more precisely, improving both efficacy and safety. medtechtomarket.com/latest-news/...

Ready to elevate your understanding of immunology? 🧑‍🎓 Our Foundations of immunology course starts on 2 Oct, exploring innate & adaptive immunity, vaccines & immunotherapies. Past attendees experienced a 76% boost in confidence. Register today: vist.ly/59szg

Jack went to @liverpooluni.bsky.social MIC @livuniresearch.bsky.social this week, for their microbiome research day. Great to hear about lots of interesting research!

Jack spoke with John Storton from @yellowspidermedia.bsky.social about our IVD development capabilities - developing medical diagnostics from concept through to commercial launch open.spotify.com/episode/6VnS...

Whichever TRL your diagnostic technology is at, Medtechtomarket Ltd can work with you to take it to market. medtechtomarket.com

Science Briefing Feasibility of Type 1 Diabetes Screening in the UK: The ELSA Study Key Highlights Medicine · Diabetes & Endocrinology Researchers have reported a correction to the feasibility study on general population screening for type 1 diabetes in the UK, known as the ELSA study. The…

France reports first Ebola case after doctor returning from DR Congo tests positive

Companion Diagnostics (CDx): What’s Driving the Increase in Pharma Demand? medtechtomarket.com/latest-news/...

Investors want confidence. Regulators want evidence. Patients need reliability. TRLs help diagnostics developers deliver all 3 medtechtomarket.com/podcast/

The mid stages of diagnostic development (or product development in general) are tricky to navigate. For many reasons, they are often called the 'Valley of Death' medtechtomarket.com/podcast/

Whichever TRL your diagnostic technology is at, Medtechtomarket Ltd can work with you to take it to market. medtechtomarket.com

Using these clues, can you guess who invented Technology Readiness levels (TRLs)?? medtechtomarket.com/podcast/

Companion diagnostics (CDx) match patients to targeted therapies by identifying specific biological markers, predicting who will respond well to treatment as well as those who might be at risk of serious adverse side effects. medtechtomarket.com/latest-news/...

Why might some researchers think that their medical diagnostic development is further ahead than it actually is? Jack Fitzpatrick & John Storton discuss the importance of TRLs in the latest Medtechtomarket Ltd podcast 🎙️ medtechtomarket.com/podcast/ 🎥 @yellowspidermedia.bsky.social

Investors want confidence. Regulators want evidence. Patients need reliability. TRLs help diagnostics developers deliver all 3 Jack Fitzpatrick & @yellowspidermedia.bsky.social explore stronger development pathways, faster decision-making & more successful product launches in medical technology

Risk management in diagnostics development - the importance of TRLs Full episode on YouTube: youtu.be/2p5dw0eqIdo?... Full episode on Spotify: open.spotify.com/episode/3EU1... 🎥 @yellowspidermedia.bsky.social

Want to know the difference between an idea and a viable diagnostic product? Watch or listen to the Medtechtomarket podcast with Jack Fitzpatrick & John Storton @yellowspidermedia.bsky.social using the links below: YouTube: youtu.be/2p5dw0eqIdo?... Spotify: open.spotify.com/episode/3EU1...

Improving lives around the world with accelerated IVD development www.youtube.com/watch?v=UHKz...

We’ve put together a selection of articles from our Clinical Science journal for Diabetes Week. Have a read and learn more about the research shaping our understanding of diabetes. 🧪

WATCH: The importance of Technology Readiness Levels (TRLs) in product development & diagnostic development youtu.be/2p5dw0eqIdo?...

Whichever TRL your diagnostic technology is at, Medtechtomarket Ltd can work with you to take it to market. medtechtomarket.com

One important issue with Femtech development is continuous monitoring. Traditionally, medical diagnostics have been a snapshot at the time a sample was taken. This might not be enough for conditions related to the menstrual cycle, for example. medtechtomarket.com/latest-news/...

We had a brilliant morning at @liverpooluni.bsky.social for the Liverpool Women’s Health Innovation (WIN) Studio: Device Exhibition. It was amazing to see live demos of emerging women’s health innovations (a few we worked on too!) as well as connecting with the WIN Studio team and collaborators

The industry norm for fully FDA/CE compliant and accredited diagnostic systems’ entire life cycle, from concept to commercial launch is approximately ≥8 years. We can do it in less than 4 years. Achieve market success faster with Medtechtomarket medtechtomarket.com

Great diagnostics don’t fail because of bad ideas, they fail because they scale too soon. In our first-ever Medtechtomarket podcast, John Storton (@yellowspidermedia.bsky.social) & Dr Jack Fitzpatrick unpack Technology Readiness Levels (TRLs) youtu.be/2p5dw0eqIdo

From state-of-the-art microfluidic immunofluorescence to traditional lateral flow technologies, we employ a range of immunological techniques to determine markers for clinical chemistry and haematology (hematology) point-of-care diagnostic applications youtu.be/o2exf3MzK-0

Successful diagnostic product development requires the best laboratory conditions and equipment. youtu.be/j_me3ZTmjd4

Our medical diagnostics events page has been updated... medtechtomarket.com/medical-diag...

The importance of technology Readiness Levels (TRLs) in product development and diagnostics development: www.youtube.com/watch?v=2p5d...

Whichever TRL your diagnostic technology is at, Medtechtomarket Ltd can work with you to take it to market. medtechtomarket.com

Following the outbreak of Andes hantavirus disease on the cruise ship MV Hondius, UK universities, including @liverpooluni.bsky.social, and @ukhsa.bsky.social launched a new clinical study to characterise infection and disease associated with Andes hantavirus. news.liverpool.ac.uk/2026/05/21/u...

What happens at each stage of diagnostic development? When do Regulators and investors get involved in product development? At which stage should you partner with a CDMO? Find out here: youtu.be/2p5dw0eqIdo?...

Full life-cycle services to develop your medical diagnostics www.youtube.com/watch?v=UHKz...

In healthcare, “almost ready” isn’t ready enough. The path from breakthrough science to clinical reality is full of risk...

How to reduce problems during the product development process medtechtomarket.com/latest-news/... #diagnostics #IVD #CDMO

Did you know? We just launched a podcast! More information here: medtechtomarket.com/podcast/

Today is Clinical Trials Day, recognised worldwide on May 20th to honour the date in 1747 when James Lind began the first randomised clinical trial aboard the HMS Salisbury, which studied scurvy treatments.

The industry norm for fully FDA/CE compliant and accredited diagnostic systems’ entire life cycle, from concept to commercial launch is approximately ≥8 years. We can do it in less than 4 years. Achieve market success faster with Medtechtomarket

What separates breakthrough diagnostics from expensive dead ends? A clear path to readiness We explore why Technology Readiness Levels are essential for medical device & diagnostics teams navigating R&D, regulatory expectations & investor confidence youtu.be/2p5dw0eqIdo?si=kZHFZdTGKFxU2trM

7 reasons to outsource to a CDMO for assay development and manufacturing medtechtomarket.com/latest-news/...

Liverpool City Region venture helps combat Rwanda Mpox outbreak lbndaily.co.uk/wirral-ventu...

🎙️ Great diagnostics don’t fail because of bad ideas - they fail because they scale too soon. John Storton (@yellowspidermedia.bsky.social) & Jack Fitzpatrick unpack Technology Readiness Levels (TRLs) to reduce risk, validate performance & move from concept to commercialisation youtu.be/2p5dw0eqIdo

Whichever TRL your diagnostic technology is at, Medtechtomarket Ltd can work with you to take it to market. medtechtomarket.com

Our team is enjoying the Women's Health Conference at @uniofhull.bsky.social today

Almost half way through the year, were our team right with their predictions? www.youtube.com/watch?v=fUzH...

PCOS gets a new name: PMOS. 🌐 Experts worldwide agree it's time to stop the cyst confusion and recognize this as a multisystem disorder. Find out why this matters for 170 million women. 👀 www.news-medical.net/news/2026051... #PCOS #WomensHealth #Endocrinology @thelancet.com

From state-of-the-art microfluidic immunofluorescence to traditional lateral flow technologies, we employ a range of immunological techniques to determine markers for clinical chemistry and haematology (hematology) point-of-care diagnostic applications www.youtube.com/watch?v=o2ex...